Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals
Authored by Sylvie Deuffic-Burban, Yazdan Yazdanpanah, Romain Ragonnet, Christoph Boesecke, Marguerite Guiguet, Karine Lacombe, Jeremie Guedj, Juergen K Rockstroh
Date Published: 2017
DOI: 10.1093/ofid/ofw235
Sponsors:
No sponsors listed
Platforms:
No platforms listed
Model Documentation:
Other Narrative
Model Code URLs:
Model code not found
Abstract
Background. Hepatitis C virus (HCV) infection is often asymptomatic, and
the date of infection is almost impossible to determine. Furthermore,
spontaneous clearance (SC) may occur, but little is known about its time
of occurrence.
Methods. Data on human immunodeficiency virus (HIV)-HCV coinfected
individuals were used to inform a stochastic simulation model of HCV
viral load kinetics, alanine aminotransferase (ALT), and HCV antibodies
during acute hepatitis C. The dates of diagnosis and potential SC were
estimated through a Bayesian approach. Hepatitis C virus diagnosis was
assumed to be based on an elevated ALT level detected during a control
visit for HIV-infected individuals, which occurred every 3 months
(scenario A) or every 6 months (scenario B).
Results. We found that HCV diagnosis occurred after a median of 115 days
and 170 days of infection in scenarios A and B, respectively. Among
spontaneous clearers, SC occurred after a median time of 184 days after
infection. Seven percent (scenario B) to 10\% (scenario A) of SCs
appeared more than 6 months after diagnosis, and 3\% (both scenarios) of
SCs appeared more than 1 year after diagnosis.
Conclusions. Acute hepatitis C diagnosis occurs late in HIV-HCV
coinfected individuals. Screening for HCV in HIV-infected individuals
should be performed frequently to reduce delays. Our findings about late
occurrence of SC support ``wait and see{''} strategies for treatment
initiation from an individual basis. However, early treatment initiation
may reduce HCV transmission.
Tags
Agent-based modeling
Dynamics
population
Diseases
Responses
Viral load
Men
Natural-history
Hcv antibodies
Late diagnosis
Natural history
Acute hcv infection
Hiv-positive msm
Acute-phase